NEW YORK – Genomic techniques that could allow early detection and screening for virus-associated cancers are making strides, according to project leaders who described their efforts last week at a conference on liquid biopsy technologies sponsored by the American Association for Cancer Research.
Chinese University of Hong Kong investigator Dennis Lo, a pioneer in the field, updated attendees in his keynote speech at the meeting on his work to develop an early detection test for nasopharyngeal cancers precipitated by the Epstein-Barr virus (EBV).